pentetic acid has been researched along with Cardiomyopathy, Hypertrophic in 6 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Norikane, T | 1 |
| Yamamoto, Y | 1 |
| Kengo, F | 1 |
| Takami, Y | 1 |
| Mitamura, K | 1 |
| Noma, T | 1 |
| Nishiyama, Y | 1 |
| Koito, H | 1 |
| Suzuki, J | 1 |
| Nakamori, H | 1 |
| Ohkubo, N | 1 |
| Wakayama, Y | 1 |
| Iwasaka, T | 1 |
| Inada, M | 1 |
| Katoh, T | 1 |
| Miyanaga, H | 1 |
| Kawasaki, S | 1 |
| Yoneyama, S | 1 |
| Hyougo, T | 1 |
| Kamitani, T | 1 |
| Takahashi, T | 1 |
| Kunishige, H | 1 |
| Aso, H | 1 |
| Takeda, K | 1 |
| Ito, T | 1 |
| Shiraishi, T | 1 |
| Matsumura, K | 1 |
| Nakagawa, T | 1 |
| Nishimura, T | 1 |
| Yamada, N | 1 |
| Haze, K | 1 |
| Nagata, S | 1 |
| Mabuchi, N | 1 |
| Hamada, T | 1 |
| Ishikawa, K | 1 |
| Sakashita, T | 1 |
| Shiba, Y | 1 |
| Asai, Y | 1 |
| Takada, H | 1 |
| Matsumoto, F | 1 |
| Iwamoto, S | 1 |
| Kumano, M | 1 |
6 other studies available for pentetic acid and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Hypertrophic cardiomyopathy incidentally detected by 99mTc-HAS-D scintigraphy.
Topics: Cardiomyopathy, Hypertrophic; Echocardiography; Humans; Incidental Findings; Male; Middle Aged; Pent | 2021 |
[Clinical significance of abnormal high signal intensity of left ventricular myocardium by gadolinium-diethylenetriaminepenta-acetic acid enhanced magnetic resonance imaging in hypertrophic cardiomyopathy].
Topics: Adolescent; Adult; Aged; Cardiomyopathy, Hypertrophic; Echocardiography; Electrocardiography; Female | 1995 |
[Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
Topics: Aged; Cardiomegaly; Cardiomyopathy, Hypertrophic; Diagnosis, Differential; Fatty Acids; Female; Gado | 1997 |
Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging.
Topics: Analysis of Variance; Animals; Autoradiography; Cardiomyopathy, Hypertrophic; Contrast Media; Cricet | 1998 |
Experience using gadolinium-DTPA in cardiovascular MRI.
Topics: Cardiomyopathy, Hypertrophic; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic | 1991 |
[Clinical comparison of 99mTc-diethylenetriaminepentaacetic acid-human serum albumin (99mTc-HSA-D) and 99mTc-human serum albumin (99mTc-HSA) for cardiac blood pool imaging].
Topics: Aged; Aortic Valve Stenosis; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiovascular D | 1988 |